|
Diabetes, Vol 39, Issue 4 477-482, Copyright © 1990 by American Diabetes Association
Bone and mineral metabolism in BB rats with long-term diabetes. Decreased bone turnover and osteoporosis
J Verhaeghe, E van Herck, WJ Visser, AM Suiker, M Thomasset, TA Einhorn, E Faierman and R Bouillon
Laboratory for Experimental Medicine and Endocrinology, Katholieke Universiteit Leuven, Belgium.
The effect of long-term diabetes mellitus on bone and mineral metabolism
was studied in BB rats. Diabetic rats were treated with 1 U of long-acting
insulin every other day for 12 wk and compared with nondiabetic
littermates. Urinary calcium excretion was increased greater than 10-fold,
but serum total and diffusible calcium remained normal. Serum
concentrations of both 1 alpha, 25-dihydroxyvitamin D3 and vitamin
D-binding protein were significantly decreased in diabetic rats. The
intestinal calbindin-D 9K concentration was decreased by nearly 50%, and
active duodenal calcium absorption was totally abolished. Trabecular bone
volume measured in the tibial metaphysis was decreased by 44%, and the
osteoblast and osteoid surfaces were less than 10% of values observed in
control rats, whereas the osteoclast surface was unchanged by diabetes. The
daily bone formation (bone mineral apposition rate) measured by labeling
twice with calcein was decreased by 86% in diabetic rats. The serum
concentration of osteocalcin, a biochemical marker of osteoblast function,
was similarly decreased (mean +/- SE 23 +/- 3 and 62 +/- 4 micrograms/L in
diabetic [n = 15] and nondiabetic [n = 15] rats, respectively). Serum
osteocalcin was significantly correlated with the serum concentration of
insulinlike growth factor I (r = 0.89, P less than 0.001). Bone strength
measured as the energy needed to fracture the femur was markedly decreased
(5.3 +/- 1.4 and 8.4 +/- 1.3 N.m.degree in diabetic and nondiabetic rats,
respectively; P less than 0.01). These histological, chemical, and
biomechanical data clearly indicate that long-standing diabetes in BB rats
results in severe low-turnover osteoporosis probably related to decreased
osteoblast recruitment and/or function.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Fulzele, D. J. DiGirolamo, Z. Liu, J. Xu, J. L. Messina, and T. L. Clemens
Disruption of the Insulin-like Growth Factor Type 1 Receptor in Osteoblasts Enhances Insulin Signaling and Action
J. Biol. Chem.,
August 31, 2007;
282(35):
25649 - 25658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Irwin, H. V. Lin, K. J. Motyl, and L. R. McCabe
Normal Bone Density Obtained in the Absence of Insulin Receptor Expression in Bone
Endocrinology,
December 1, 2006;
147(12):
5760 - 5767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Thrailkill, C. K. Lumpkin Jr., R. C. Bunn, S. F. Kemp, and J. L. Fowlkes
Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues
Am J Physiol Endocrinol Metab,
November 1, 2005;
289(5):
E735 - E745.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Botolin, M.-C. Faugere, H. Malluche, M. Orth, R. Meyer, and L. R. McCabe
Increased Bone Adiposity and Peroxisomal Proliferator-Activated Receptor-{gamma}2 Expression in Type I Diabetic Mice
Endocrinology,
August 1, 2005;
146(8):
3622 - 3631.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K Walti, M. B Zimmermann, T. Walczyk, G. A Spinas, and R. F Hurrell
Measurement of magnesium absorption and retention in type 2 diabetic patients with the use of stable isotopes
Am. J. Clinical Nutrition,
September 1, 2003;
78(3):
448 - 453.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zayzafoon, S. Botolin, and L. R. McCabe
p38 and Activating Transcription Factor-2 Involvement in Osteoblast Osmotic Response to Elevated Extracellular Glucose
J. Biol. Chem.,
September 27, 2002;
277(40):
37212 - 37218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Vanderschueren, L. Vandenput, S. Boonen, E. Van Herck, J. V. Swinnen, and R. Bouillon
An Aged Rat Model of Partial Androgen Deficiency: Prevention of Both Loss of Bone and Lean Body Mass by Low-Dose Androgen Replacement
Endocrinology,
May 1, 2000;
141(5):
1642 - 1647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Pereira, F. Blanquaert, and E. Canalis
Cortisol Enhances the Expression of mac25/Insulin-Like Growth Factor-Binding Protein-Related Protein-1 in Cultured Osteoblasts
Endocrinology,
January 1, 1999;
140(1):
228 - 232.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. Vanderschueren, E. Van Herck, J. Nijs, A. G. H. Ederveen, R. De Coster, and R. Bouillon
Aromatase Inhibition Impairs Skeletal Modeling and Decreases Bone Mineral Density in Growing Male Rats
Endocrinology,
June 1, 1997;
138(6):
2301 - 2307.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1990 by the American Diabetes Association.
|
|
| |
|